Share Price and Basic Stock Data
Last Updated: January 9, 2026, 7:52 pm
| PEG Ratio | -12.98 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CDG Petchem Ltd operates in the Packaging & Containers industry and has faced significant revenue fluctuations over recent years. The company reported sales of ₹50.85 Cr for the fiscal year ending March 2023, a decline from ₹53.40 Cr in the prior year. Notably, sales have dramatically decreased from a peak of ₹89.40 Cr in March 2020 to ₹40.53 Cr in March 2024, indicating a consistent downward trend. In the last quarter reported for September 2023, the company generated ₹11.73 Cr in sales, which further dropped to ₹10.88 Cr in December 2023. This volatility raises concerns about market demand and operational stability. Despite the challenges, CDG Petchem’s revenue per share stood at ₹75.06 for the fiscal year ending March 2025, down from ₹131.69 in March 2024, highlighting a troubling trajectory in revenue generation capabilities. Overall, the company’s revenue trends signal significant challenges that need addressing to stabilize and grow in a competitive market.
Profitability and Efficiency Metrics
CDG Petchem’s profitability metrics reflect a concerning financial performance, with a reported net profit of -₹1.16 Cr for the fiscal year ending March 2025, indicating continued losses. The operating profit margin (OPM) stood at -3.81%, a stark contrast to the industry’s typical margins, which usually hover in the positive range. The company’s interest coverage ratio (ICR) is alarming at -0.40x, underscoring the inability to meet interest obligations from operating profits. The return on equity (ROE) registered an extraordinary 351%, although this figure is misleading due to negative net income. The cash conversion cycle (CCC) stood at 114.71 days, reflecting inefficiencies in managing inventory and receivables. These metrics collectively portray a company struggling to maintain profitability and operational efficiency, leaving it vulnerable to financial distress and market competition.
Balance Sheet Strength and Financial Ratios
CDG Petchem’s balance sheet reveals several red flags, particularly concerning its capital structure and liquidity. The company reported total borrowings of ₹5.76 Cr against reserves of -₹3.30 Cr, indicating a reliance on debt amid negative equity. The current ratio stood at 12.08, suggesting a strong liquidity position; however, this is overshadowed by the negative book value per share of -₹0.71. The total debt to equity ratio is alarming at -26.07, reflecting a precarious financial standing where liabilities exceed assets. Additionally, the price-to-book value (P/BV) ratio is recorded at -54.69x, further highlighting the distress in shareholder equity. Such imbalances raise significant concerns about the company’s ability to finance operations and growth sustainably. The financial ratios indicate a company that may struggle to meet its long-term obligations, creating potential risks for stakeholders.
Shareholding Pattern and Investor Confidence
The shareholding pattern of CDG Petchem illustrates a notable shift in investor confidence. As of March 2025, promoters hold 20.69% of the company, a significant drop from 62.10% just a year earlier, indicating a potential loss of confidence from the founding members. Institutional investors hold a meager 0.70% stake, with foreign institutional investors (FIIs) not present, which raises questions about institutional backing. The public holds 78.61% of the shares, reflecting a high retail investor presence. The number of shareholders has also decreased to 1,476 from 1,585 in December 2022, suggesting a decline in interest or confidence among retail investors. This shifting shareholding pattern poses risks for stability and governance, as a lack of significant promoter and institutional support can lead to volatility and challenges in strategic decision-making.
Outlook, Risks, and Final Insight
CDG Petchem faces a challenging outlook characterized by financial instability and operational inefficiencies. The company’s recent performance indicates substantial risks, including declining revenues, persistent losses, and a precarious balance sheet. The negative cash flow situation, coupled with high debt levels, heightens the risk of insolvency if not addressed promptly. However, potential strengths include a significant liquidity position and a large public shareholder base, which could be leveraged for future capital raises. If CDG Petchem successfully implements operational improvements and re-establishes revenue growth, it could stabilize its financial metrics. Conversely, failure to address these challenges could lead to further deterioration of its market position and investor confidence. The path forward will require strategic realignment and effective management to navigate the competitive landscape effectively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Tin Works Ltd | 122 Cr. | 117 | 209/107 | 11.1 | 210 | 0.68 % | 7.95 % | 5.88 % | 10.0 |
| Gujarat Containers Ltd | 92.7 Cr. | 164 | 188/154 | 13.4 | 94.4 | 0.91 % | 18.4 % | 17.4 % | 10.0 |
| Goblin India Ltd | 16.2 Cr. | 11.8 | 34.5/10.3 | 22.0 | 32.8 | 0.00 % | 7.73 % | 4.63 % | 10.0 |
| G K P Printing & Packaging Ltd | 15.4 Cr. | 6.98 | 10.4/4.85 | 18.7 | 10.4 | 0.00 % | 4.87 % | 3.87 % | 10.0 |
| Garware Hi Tech Films Ltd | 7,064 Cr. | 3,041 | 4,800/2,317 | 22.6 | 1,079 | 0.39 % | 20.6 % | 15.0 % | 10.0 |
| Industry Average | 1,899.72 Cr | 307.65 | 53.20 | 189.00 | 0.34% | 12.76% | 24.70% | 7.38 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 14.31 | 9.39 | 13.82 | 10.59 | 11.73 | 10.88 | 7.33 | 6.36 | 6.04 | 5.45 | 5.25 | 0.22 | 22.18 |
| Expenses | 14.06 | 9.19 | 13.68 | 10.30 | 11.39 | 11.44 | 7.22 | 6.53 | 6.08 | 5.46 | 5.45 | 0.24 | 18.17 |
| Operating Profit | 0.25 | 0.20 | 0.14 | 0.29 | 0.34 | -0.56 | 0.11 | -0.17 | -0.04 | -0.01 | -0.20 | -0.02 | 4.01 |
| OPM % | 1.75% | 2.13% | 1.01% | 2.74% | 2.90% | -5.15% | 1.50% | -2.67% | -0.66% | -0.18% | -3.81% | -9.09% | 18.08% |
| Other Income | 0.01 | 0.26 | 0.00 | 0.06 | 0.00 | 0.68 | 0.00 | 0.06 | 0.02 | 0.00 | 0.10 | 0.16 | 0.27 |
| Interest | 0.28 | 0.23 | 0.52 | 0.26 | 0.28 | 0.27 | 0.50 | 0.22 | 0.16 | 0.00 | 0.23 | 0.00 | 0.42 |
| Depreciation | 0.06 | 0.07 | 0.03 | 0.06 | 0.04 | 0.04 | 0.07 | 0.05 | 0.05 | 0.07 | -0.02 | 0.00 | 0.98 |
| Profit before tax | -0.08 | 0.16 | -0.41 | 0.03 | 0.02 | -0.19 | -0.46 | -0.38 | -0.23 | -0.08 | -0.31 | 0.14 | 2.88 |
| Tax % | -287.50% | 0.00% | 0.00% | 33.33% | 100.00% | 78.95% | -45.65% | 7.89% | 26.09% | -12.50% | 3.23% | 7.14% | 4.86% |
| Net Profit | 0.15 | 0.16 | -0.42 | 0.03 | 0.00 | -0.34 | -0.24 | -0.41 | -0.29 | -0.06 | -0.32 | 0.14 | 2.73 |
| EPS in Rs | 0.49 | 0.62 | -1.53 | 0.06 | -0.03 | -1.66 | -1.36 | -1.33 | -0.97 | -0.19 | -0.91 | 0.15 | 1.73 |
Last Updated: January 9, 2026, 3:58 am
Below is a detailed analysis of the quarterly data for CDG Petchem Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 22.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.22 Cr. (Sep 2025) to 22.18 Cr., marking an increase of 21.96 Cr..
- For Expenses, as of Dec 2025, the value is 18.17 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.24 Cr. (Sep 2025) to 18.17 Cr., marking an increase of 17.93 Cr..
- For Operating Profit, as of Dec 2025, the value is 4.01 Cr.. The value appears strong and on an upward trend. It has increased from -0.02 Cr. (Sep 2025) to 4.01 Cr., marking an increase of 4.03 Cr..
- For OPM %, as of Dec 2025, the value is 18.08%. The value appears strong and on an upward trend. It has increased from -9.09% (Sep 2025) to 18.08%, marking an increase of 27.17%.
- For Other Income, as of Dec 2025, the value is 0.27 Cr.. The value appears strong and on an upward trend. It has increased from 0.16 Cr. (Sep 2025) to 0.27 Cr., marking an increase of 0.11 Cr..
- For Interest, as of Dec 2025, the value is 0.42 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Sep 2025) to 0.42 Cr., marking an increase of 0.42 Cr..
- For Depreciation, as of Dec 2025, the value is 0.98 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Sep 2025) to 0.98 Cr., marking an increase of 0.98 Cr..
- For Profit before tax, as of Dec 2025, the value is 2.88 Cr.. The value appears strong and on an upward trend. It has increased from 0.14 Cr. (Sep 2025) to 2.88 Cr., marking an increase of 2.74 Cr..
- For Tax %, as of Dec 2025, the value is 4.86%. The value appears to be improving (decreasing) as expected. It has decreased from 7.14% (Sep 2025) to 4.86%, marking a decrease of 2.28%.
- For Net Profit, as of Dec 2025, the value is 2.73 Cr.. The value appears strong and on an upward trend. It has increased from 0.14 Cr. (Sep 2025) to 2.73 Cr., marking an increase of 2.59 Cr..
- For EPS in Rs, as of Dec 2025, the value is 1.73. The value appears strong and on an upward trend. It has increased from 0.15 (Sep 2025) to 1.73, marking an increase of 1.58.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 4:04 am
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.35 | 32.20 | 67.06 | 89.40 | 39.42 | 53.40 | 50.85 | 40.53 | 23.10 |
| Expenses | 4.47 | 31.92 | 65.65 | 87.98 | 39.09 | 54.03 | 50.00 | 40.34 | 23.53 |
| Operating Profit | -1.12 | 0.28 | 1.41 | 1.42 | 0.33 | -0.63 | 0.85 | 0.19 | -0.43 |
| OPM % | -33.43% | 0.87% | 2.10% | 1.59% | 0.84% | -1.18% | 1.67% | 0.47% | -1.86% |
| Other Income | 1.68 | 1.24 | 1.31 | 1.23 | 1.60 | 0.48 | 0.36 | 0.73 | 0.17 |
| Interest | 0.01 | 0.46 | 1.50 | 1.29 | 1.56 | 1.63 | 1.35 | 1.31 | 0.66 |
| Depreciation | 0.12 | 0.12 | 0.32 | 0.30 | 0.34 | 0.41 | 0.28 | 0.20 | 0.14 |
| Profit before tax | 0.43 | 0.94 | 0.90 | 1.06 | 0.03 | -2.19 | -0.42 | -0.59 | -1.06 |
| Tax % | 2.33% | 44.68% | 23.33% | 23.58% | 600.00% | 5.48% | -9.52% | -6.78% | 8.49% |
| Net Profit | 0.42 | 0.52 | 0.70 | 0.81 | -0.15 | -2.32 | -0.38 | -0.56 | -1.16 |
| EPS in Rs | 1.36 | 1.69 | 2.27 | 2.63 | -0.49 | -7.54 | -1.30 | -2.40 | -3.61 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 23.81% | 34.62% | 15.71% | -118.52% | -1446.67% | 83.62% | -47.37% | -107.14% |
| Change in YoY Net Profit Growth (%) | 0.00% | 10.81% | -18.90% | -134.23% | -1328.15% | 1530.29% | -130.99% | -59.77% |
CDG Petchem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -24% |
| 3 Years: | -24% |
| TTM: | -43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 15% |
| TTM: | -52% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 54% |
| 1 Year: | 43% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -41% |
| 3 Years: | -63% |
| Last Year: | -331% |
Last Updated: September 5, 2025, 2:51 pm
Balance Sheet
Last Updated: July 25, 2025, 1:37 pm
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 |
| Reserves | -0.07 | -0.10 | 0.60 | 1.41 | 1.26 | -1.06 | -1.46 | -2.19 | -3.30 |
| Borrowings | 0.07 | 4.79 | 2.59 | 12.25 | 18.23 | 17.36 | 15.56 | 11.56 | 5.76 |
| Other Liabilities | 2.71 | 14.44 | 18.57 | 12.88 | 6.11 | 7.91 | 2.90 | 4.50 | 6.51 |
| Total Liabilities | 5.79 | 22.21 | 24.84 | 29.62 | 28.68 | 27.29 | 20.08 | 16.95 | 12.05 |
| Fixed Assets | 0.66 | 3.78 | 3.31 | 3.07 | 6.60 | 6.60 | 5.49 | 4.86 | 3.25 |
| CWIP | 1.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.20 | 0.01 | 0.01 | 0.00 |
| Other Assets | 3.57 | 18.43 | 21.53 | 26.55 | 22.08 | 20.49 | 14.58 | 12.08 | 8.45 |
| Total Assets | 5.79 | 22.21 | 24.84 | 29.62 | 28.68 | 27.29 | 20.08 | 16.95 | 12.05 |
Below is a detailed analysis of the balance sheet data for CDG Petchem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 3.08 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.08 Cr..
- For Reserves, as of Mar 2025, the value is -3.30 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -2.19 Cr. (Mar 2024) to -3.30 Cr., marking a decline of 1.11 Cr..
- For Borrowings, as of Mar 2025, the value is 5.76 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 11.56 Cr. (Mar 2024) to 5.76 Cr., marking a decrease of 5.80 Cr..
- For Other Liabilities, as of Mar 2025, the value is 6.51 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.50 Cr. (Mar 2024) to 6.51 Cr., marking an increase of 2.01 Cr..
- For Total Liabilities, as of Mar 2025, the value is 12.05 Cr.. The value appears to be improving (decreasing). It has decreased from 16.95 Cr. (Mar 2024) to 12.05 Cr., marking a decrease of 4.90 Cr..
- For Fixed Assets, as of Mar 2025, the value is 3.25 Cr.. The value appears to be declining and may need further review. It has decreased from 4.86 Cr. (Mar 2024) to 3.25 Cr., marking a decrease of 1.61 Cr..
- For CWIP, as of Mar 2025, the value is 0.35 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 0.35 Cr., marking an increase of 0.35 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 0.01 Cr..
- For Other Assets, as of Mar 2025, the value is 8.45 Cr.. The value appears to be declining and may need further review. It has decreased from 12.08 Cr. (Mar 2024) to 8.45 Cr., marking a decrease of 3.63 Cr..
- For Total Assets, as of Mar 2025, the value is 12.05 Cr.. The value appears to be declining and may need further review. It has decreased from 16.95 Cr. (Mar 2024) to 12.05 Cr., marking a decrease of 4.90 Cr..
However, the Borrowings (5.76 Cr.) are higher than the Reserves (-3.30 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -1.19 | -4.51 | -1.18 | -10.83 | -17.90 | -17.99 | -14.71 | -11.37 | -6.19 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 302.90 | 132.40 | 84.75 | 79.98 | 159.81 | 93.51 | 73.65 | 85.73 | 114.71 |
| Inventory Days | 0.00 | 50.01 | 18.54 | 55.40 | 108.80 | 0.00 | |||
| Days Payable | 160.93 | 101.30 | 46.45 | 573.82 | |||||
| Cash Conversion Cycle | 302.90 | 21.48 | 1.99 | 79.98 | 159.81 | 93.51 | 82.60 | -379.29 | 114.71 |
| Working Capital Days | 70.82 | 36.50 | 7.78 | 25.93 | 30.65 | 5.67 | 9.04 | 3.24 | 111.40 |
| ROCE % | 25.81% | 34.05% | 20.34% | 7.84% | -2.72% | 5.62% | 4.87% | -4.34% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -3.74 | -1.80 | -1.24 | -7.53 | -0.49 |
| Diluted EPS (Rs.) | -3.74 | -1.80 | -1.24 | -7.53 | -0.49 |
| Cash EPS (Rs.) | -3.29 | -1.15 | -0.34 | -6.19 | 0.59 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -0.71 | 2.87 | 5.48 | 6.55 | 14.09 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -0.71 | 2.87 | 5.48 | 6.55 | 14.09 |
| Revenue From Operations / Share (Rs.) | 75.06 | 131.69 | 165.24 | 173.53 | 128.07 |
| PBDIT / Share (Rs.) | -0.86 | 2.99 | 3.93 | -0.49 | 6.27 |
| PBIT / Share (Rs.) | -1.31 | 2.34 | 3.03 | -1.83 | 5.17 |
| PBT / Share (Rs.) | -3.44 | -1.93 | -1.35 | -7.14 | 0.09 |
| Net Profit / Share (Rs.) | -3.74 | -1.80 | -1.24 | -7.53 | -0.49 |
| NP After MI And SOA / Share (Rs.) | -3.59 | -2.39 | -1.29 | -7.53 | -0.49 |
| PBDIT Margin (%) | -1.14 | 2.27 | 2.37 | -0.28 | 4.89 |
| PBIT Margin (%) | -1.74 | 1.77 | 1.83 | -1.05 | 4.04 |
| PBT Margin (%) | -4.58 | -1.46 | -0.81 | -4.11 | 0.07 |
| Net Profit Margin (%) | -4.98 | -1.36 | -0.74 | -4.33 | -0.38 |
| NP After MI And SOA Margin (%) | -4.78 | -1.81 | -0.78 | -4.33 | -0.38 |
| Return on Networth / Equity (%) | 0.00 | -83.21 | -24.50 | -114.89 | -3.50 |
| Return on Capital Employeed (%) | -3.53 | 12.84 | 13.17 | -7.00 | 14.88 |
| Return On Assets (%) | -9.16 | -4.34 | -1.97 | -8.49 | -0.52 |
| Long Term Debt / Equity (X) | -26.07 | 4.82 | 3.17 | 2.84 | 1.43 |
| Total Debt / Equity (X) | -26.07 | 13.07 | 9.61 | 8.61 | 4.01 |
| Asset Turnover Ratio (%) | 1.59 | 2.19 | 1.18 | 1.16 | 0.70 |
| Current Ratio (X) | 12.08 | 1.05 | 1.11 | 1.06 | 1.19 |
| Quick Ratio (X) | 12.07 | 0.99 | 0.90 | 0.98 | 1.01 |
| Inventory Turnover Ratio (X) | 74.38 | 24.18 | 11.01 | 10.73 | 4.81 |
| Interest Coverage Ratio (X) | -0.40 | 0.69 | 0.89 | -0.09 | 1.23 |
| Interest Coverage Ratio (Post Tax) (X) | -0.75 | 0.57 | 0.71 | -0.41 | 0.90 |
| Enterprise Value (Cr.) | 17.72 | 23.53 | 20.23 | 22.46 | 24.30 |
| EV / Net Operating Revenue (X) | 0.76 | 0.58 | 0.39 | 0.42 | 0.61 |
| EV / EBITDA (X) | -66.93 | 25.58 | 16.74 | -148.15 | 12.60 |
| MarketCap / Net Operating Revenue (X) | 0.52 | 0.29 | 0.09 | 0.09 | 0.17 |
| Price / BV (X) | -54.69 | 13.47 | 2.91 | 2.63 | 1.63 |
| Price / Net Operating Revenue (X) | 0.52 | 0.29 | 0.09 | 0.09 | 0.17 |
| EarningsYield | -0.09 | -0.06 | -0.08 | -0.43 | -0.02 |
After reviewing the key financial ratios for CDG Petchem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -3.74. This value is below the healthy minimum of 5. It has decreased from -1.80 (Mar 24) to -3.74, marking a decrease of 1.94.
- For Diluted EPS (Rs.), as of Mar 25, the value is -3.74. This value is below the healthy minimum of 5. It has decreased from -1.80 (Mar 24) to -3.74, marking a decrease of 1.94.
- For Cash EPS (Rs.), as of Mar 25, the value is -3.29. This value is below the healthy minimum of 3. It has decreased from -1.15 (Mar 24) to -3.29, marking a decrease of 2.14.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -0.71. It has decreased from 2.87 (Mar 24) to -0.71, marking a decrease of 3.58.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -0.71. It has decreased from 2.87 (Mar 24) to -0.71, marking a decrease of 3.58.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 75.06. It has decreased from 131.69 (Mar 24) to 75.06, marking a decrease of 56.63.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.86. This value is below the healthy minimum of 2. It has decreased from 2.99 (Mar 24) to -0.86, marking a decrease of 3.85.
- For PBIT / Share (Rs.), as of Mar 25, the value is -1.31. This value is below the healthy minimum of 0. It has decreased from 2.34 (Mar 24) to -1.31, marking a decrease of 3.65.
- For PBT / Share (Rs.), as of Mar 25, the value is -3.44. This value is below the healthy minimum of 0. It has decreased from -1.93 (Mar 24) to -3.44, marking a decrease of 1.51.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -3.74. This value is below the healthy minimum of 2. It has decreased from -1.80 (Mar 24) to -3.74, marking a decrease of 1.94.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -3.59. This value is below the healthy minimum of 2. It has decreased from -2.39 (Mar 24) to -3.59, marking a decrease of 1.20.
- For PBDIT Margin (%), as of Mar 25, the value is -1.14. This value is below the healthy minimum of 10. It has decreased from 2.27 (Mar 24) to -1.14, marking a decrease of 3.41.
- For PBIT Margin (%), as of Mar 25, the value is -1.74. This value is below the healthy minimum of 10. It has decreased from 1.77 (Mar 24) to -1.74, marking a decrease of 3.51.
- For PBT Margin (%), as of Mar 25, the value is -4.58. This value is below the healthy minimum of 10. It has decreased from -1.46 (Mar 24) to -4.58, marking a decrease of 3.12.
- For Net Profit Margin (%), as of Mar 25, the value is -4.98. This value is below the healthy minimum of 5. It has decreased from -1.36 (Mar 24) to -4.98, marking a decrease of 3.62.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -4.78. This value is below the healthy minimum of 8. It has decreased from -1.81 (Mar 24) to -4.78, marking a decrease of 2.97.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -83.21 (Mar 24) to 0.00, marking an increase of 83.21.
- For Return on Capital Employeed (%), as of Mar 25, the value is -3.53. This value is below the healthy minimum of 10. It has decreased from 12.84 (Mar 24) to -3.53, marking a decrease of 16.37.
- For Return On Assets (%), as of Mar 25, the value is -9.16. This value is below the healthy minimum of 5. It has decreased from -4.34 (Mar 24) to -9.16, marking a decrease of 4.82.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -26.07. This value is below the healthy minimum of 0.2. It has decreased from 4.82 (Mar 24) to -26.07, marking a decrease of 30.89.
- For Total Debt / Equity (X), as of Mar 25, the value is -26.07. This value is within the healthy range. It has decreased from 13.07 (Mar 24) to -26.07, marking a decrease of 39.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.59. It has decreased from 2.19 (Mar 24) to 1.59, marking a decrease of 0.60.
- For Current Ratio (X), as of Mar 25, the value is 12.08. This value exceeds the healthy maximum of 3. It has increased from 1.05 (Mar 24) to 12.08, marking an increase of 11.03.
- For Quick Ratio (X), as of Mar 25, the value is 12.07. This value exceeds the healthy maximum of 2. It has increased from 0.99 (Mar 24) to 12.07, marking an increase of 11.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 74.38. This value exceeds the healthy maximum of 8. It has increased from 24.18 (Mar 24) to 74.38, marking an increase of 50.20.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -0.40. This value is below the healthy minimum of 3. It has decreased from 0.69 (Mar 24) to -0.40, marking a decrease of 1.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.75. This value is below the healthy minimum of 3. It has decreased from 0.57 (Mar 24) to -0.75, marking a decrease of 1.32.
- For Enterprise Value (Cr.), as of Mar 25, the value is 17.72. It has decreased from 23.53 (Mar 24) to 17.72, marking a decrease of 5.81.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.58 (Mar 24) to 0.76, marking an increase of 0.18.
- For EV / EBITDA (X), as of Mar 25, the value is -66.93. This value is below the healthy minimum of 5. It has decreased from 25.58 (Mar 24) to -66.93, marking a decrease of 92.51.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 24) to 0.52, marking an increase of 0.23.
- For Price / BV (X), as of Mar 25, the value is -54.69. This value is below the healthy minimum of 1. It has decreased from 13.47 (Mar 24) to -54.69, marking a decrease of 68.16.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 24) to 0.52, marking an increase of 0.23.
- For EarningsYield, as of Mar 25, the value is -0.09. This value is below the healthy minimum of 5. It has decreased from -0.06 (Mar 24) to -0.09, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CDG Petchem Ltd:
- Net Profit Margin: -4.98%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -3.53% (Industry Average ROCE: 12.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 24.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 12.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 320 (Industry average Stock P/E: 53.2)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -26.07
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -4.98%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | Shyam Arihant, Plot No- 10 & 11, Hyderabad Telangana 500003 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Manoj Kumar Dugar | Chairman & Managing Director |
| Mr. Rajesh Chandanmal Dugar | Non Executive Director |
| Mrs. Renu Dugar | Non Executive Woman Director |
| Mr. Manoj Kumar | Independent Director |
| Mr. Arvind Surana | Independent Director |
| Mr. Manoj Kumar Baid | Independent Director |
FAQ
What is the intrinsic value of CDG Petchem Ltd?
CDG Petchem Ltd's intrinsic value (as of 10 January 2026) is ₹650.74 which is 292.01% higher the current market price of ₹166.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹153 Cr. market cap, FY2025-2026 high/low of ₹166/26.7, reserves of ₹-3.30 Cr, and liabilities of ₹12.05 Cr.
What is the Market Cap of CDG Petchem Ltd?
The Market Cap of CDG Petchem Ltd is 153 Cr..
What is the current Stock Price of CDG Petchem Ltd as on 10 January 2026?
The current stock price of CDG Petchem Ltd as on 10 January 2026 is ₹166.
What is the High / Low of CDG Petchem Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CDG Petchem Ltd stocks is ₹166/26.7.
What is the Stock P/E of CDG Petchem Ltd?
The Stock P/E of CDG Petchem Ltd is 320.
What is the Book Value of CDG Petchem Ltd?
The Book Value of CDG Petchem Ltd is 0.71.
What is the Dividend Yield of CDG Petchem Ltd?
The Dividend Yield of CDG Petchem Ltd is 0.00 %.
What is the ROCE of CDG Petchem Ltd?
The ROCE of CDG Petchem Ltd is 5.10 %.
What is the ROE of CDG Petchem Ltd?
The ROE of CDG Petchem Ltd is 351 %.
What is the Face Value of CDG Petchem Ltd?
The Face Value of CDG Petchem Ltd is 10.0.